Androgen Receptor CAG Repeat Length and Association With Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial

Article ID	Journal	Published Year	Pages	File Type
3872933	The Journal of Urology	2010	6 Pages	PDF

Abstract

There is no association of AR CAG repeat length with prostate cancer risk. Knowledge of AR CAG repeat length provides no clinically useful information to predict prostate cancer risk.

Keywords

PSA DRE PCPT Prostate specific antigen Prostate Cancer Prevention Trial body mass index BMI digital rectal examination Prostatic neoplasms polymerase chain reaction PCR Prostate European Continental Ancestry Group African continental ancestry group Androgen Receptor Receptors, androgen

Related Topics

Health Sciences Medicine and Dentistry Nephrology

Preview

Androgen Receptor CAG Repeat Length and Association With Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial

Authors

Douglas K. Price, Cindy H. Chau, Cathee Till, Phyllis J. Goodman, Caitlin E. Baum, Sandy B. Ockers, Bevin C. English, Lori Minasian, Howard L. Parnes, Ann W. Hsing, Juergen K.V. Reichardt, Ashraful Hoque, Catherine M. Tangen, Alan R. Kristal,